Pure Global AI
NCT06350370Recruiting

Short-term and Long-term Outcomes of Colorectal Cancer Treated With Natural Orifice Specimen Extraction Surgery : a National Registry-based Study

Cancer Institute and Hospital, Chinese Academy of Medical SciencesClinicalTrials.govprocedure
Study focus
Disease/Condition
Colorectal Cancer
Drug/Device/Intervention
Natural orifice specimen extraction
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Location
Beijing, China
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2019
End date
Jan 01, 2028
Enrollment
8000 participants
Primary outcome

Rate of short-term complication

Summary

Natural orifice specimen extraction surgery (NOSES) has gained widespread recognition among
 scholars and has gradually been promoted and popularized around the world. However, the
 development of NOSES is still in the exploratory stage and there is a lack of strong evidence
 from evidence-based medicine to support its feasibility and safety, which has greatly
 affected its clinical application and development. Based on this, at the call of Professor
 Xishan Wang, the Chinese NOSES Alliance conducted a large retrospective clinical study
 involving multiple centers. By summarizing the NOSES cases of nearly 100 centers in China,
 the study aims to clarify the current status of NOSES surgery in China. Additionally, a
 comprehensive analysis and summary was conducted by combining the basic information of NOSES
 patients, perioperative data, postoperative pathological data, and follow-up information to
 further demonstrate the safety and feasibility of NOSES in the treatment of colorectal
 cancer. This study also provides more real and objective evidence-based medicine support for
 the promotion and development of NOSES surgery.

ICD-10 classifications
Malignant neoplasm of colonMalignant neoplasm: Descending colonMalignant neoplasm: Colon, unspecifiedMalignant neoplasm: Ascending colonMalignant neoplasm: Overlapping lesion of colon
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06350370
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06350370 through Pure Global AI's free database. This phase not specified trial is sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences and is currently Recruiting. The study focuses on Colorectal Cancer. Target enrollment is 8000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.